-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
On December 22, Luye Pharma announced that it had reached an agreement with Kinsey Pharmaceuticals, granting the latter Lismin transdermal patch (single-day patch) and Lismin transdermal patch (multi-day patch) in mainland China.
Lissmin transdermal patch is used to treat the symptoms of mild to moderate Alzheimer's disease.
According to the agreement, Luye Pharma has granted Jinsai Pharmaceutical the import, sales, promotion, marketing and use of Liss Ming transdermal patch (single-day patch) and Liss Ming transdermal patch (multi-day patch) in mainland China.
Note: The original text has been deleted